300 related articles for article (PubMed ID: 24387824)
1. Interobserver agreement of semi-automated and manual measurements of functional MRI metrics of treatment response in hepatocellular carcinoma.
Bonekamp D; Bonekamp S; Halappa VG; Geschwind JF; Eng J; Corona-Villalobos CP; Pawlik TM; Kamel IR
Eur J Radiol; 2014 Mar; 83(3):487-96. PubMed ID: 24387824
[TBL] [Abstract][Full Text] [Related]
2. Radiologic-pathologic analysis of contrast-enhanced and diffusion-weighted MR imaging in patients with HCC after TACE: diagnostic accuracy of 3D quantitative image analysis.
Chapiro J; Wood LD; Lin M; Duran R; Cornish T; Lesage D; Charu V; Schernthaner R; Wang Z; Tacher V; Savic LJ; Kamel IR; Geschwind JF
Radiology; 2014 Dec; 273(3):746-58. PubMed ID: 25028783
[TBL] [Abstract][Full Text] [Related]
3. Response Evaluation of Malignant Liver Lesions After TACE/SIRT: Comparison of Manual and Semi-Automatic Measurement of Different Response Criteria in Multislice CT.
Höink AJ; Schülke C; Koch R; Löhnert A; Kammerer S; Fortkamp R; Heindel W; Buerke B
Rofo; 2017 Nov; 189(11):1067-1075. PubMed ID: 28834965
[No Abstract] [Full Text] [Related]
4. Evaluation of HCC response to locoregional therapy: Validation of MRI-based response criteria versus explant pathology.
Gordic S; Corcuera-Solano I; Stueck A; Besa C; Argiriadi P; Guniganti P; King M; Kihira S; Babb J; Thung S; Taouli B
J Hepatol; 2017 Dec; 67(6):1213-1221. PubMed ID: 28823713
[TBL] [Abstract][Full Text] [Related]
5. Functional magnetic resonance imaging response of targeted tumor burden and its impact on survival in patients with hepatocellular carcinoma.
Corona-Villalobos CP; Halappa VG; Bonekamp S; Eng J; Reyes D; Cosgrove D; Rastegar N; Pan L; Pawlik TM; Kamel IR
Invest Radiol; 2015 Apr; 50(4):283-9. PubMed ID: 25396692
[TBL] [Abstract][Full Text] [Related]
6. Quantitative and volumetric European Association for the Study of the Liver and Response Evaluation Criteria in Solid Tumors measurements: feasibility of a semiautomated software method to assess tumor response after transcatheter arterial chemoembolization.
Lin M; Pellerin O; Bhagat N; Rao PP; Loffroy R; Ardon R; Mory B; Reyes DK; Geschwind JF
J Vasc Interv Radiol; 2012 Dec; 23(12):1629-37. PubMed ID: 23177109
[TBL] [Abstract][Full Text] [Related]
7. Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part II. Response stratification using volumetric functional criteria after intraarterial therapy.
Bonekamp S; Halappa VG; Geschwind JF; Li Z; Corona-Villalobos CP; Reyes D; Bhagat N; Cosgrove DP; Pawlik TM; Mezey E; Eng J; Kamel IR
Radiology; 2013 Aug; 268(2):431-9. PubMed ID: 23616632
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma: response to TACE assessed with semiautomated volumetric and functional analysis of diffusion-weighted and contrast-enhanced MR imaging data.
Bonekamp S; Jolepalem P; Lazo M; Gulsun MA; Kiraly AP; Kamel IR
Radiology; 2011 Sep; 260(3):752-61. PubMed ID: 21771960
[TBL] [Abstract][Full Text] [Related]
9. Chemoembolization for hepatocellular carcinoma: 1-month response determined with apparent diffusion coefficient is an independent predictor of outcome.
Vandecaveye V; Michielsen K; De Keyzer F; Laleman W; Komuta M; Op de beeck K; Roskams T; Nevens F; Verslype C; Maleux G
Radiology; 2014 Mar; 270(3):747-57. PubMed ID: 24475816
[TBL] [Abstract][Full Text] [Related]
10. Identifying Staging Markers for Hepatocellular Carcinoma before Transarterial Chemoembolization: Comparison of Three-dimensional Quantitative versus Non-three-dimensional Imaging Markers.
Chapiro J; Duran R; Lin M; Schernthaner RE; Wang Z; Gorodetski B; Geschwind JF
Radiology; 2015 May; 275(2):438-47. PubMed ID: 25531387
[TBL] [Abstract][Full Text] [Related]
11. Baseline and Early MR Apparent Diffusion Coefficient Quantification as a Predictor of Response of Unresectable Hepatocellular Carcinoma to Doxorubicin Drug-Eluting Bead Chemoembolization.
Kokabi N; Ludwig JM; Camacho JC; Xing M; Mittal PK; Kim HS
J Vasc Interv Radiol; 2015 Dec; 26(12):1777-86. PubMed ID: 26603497
[TBL] [Abstract][Full Text] [Related]
12. Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part I. Identification and validation of volumetric functional response criteria.
Bonekamp S; Li Z; Geschwind JF; Halappa VG; Corona-Villalobos CP; Reyes D; Pawlik TM; Bonekamp D; Eng J; Kamel IR
Radiology; 2013 Aug; 268(2):420-30. PubMed ID: 23616631
[TBL] [Abstract][Full Text] [Related]
13. Response Evaluation Criteria in Solid Tumors (RECIST) criteria are superior to European Association for Study of the Liver (EASL) criteria at 1 month follow-up for predicting long-term survival in patients treated with transarterial chemoembolization before liver transplantation for hepatocellular cancer.
Shuster A; Huynh TJ; Rajan DK; Marquez MA; Grant DR; Huynh DC; Jaskolka JD
J Vasc Interv Radiol; 2013 Jun; 24(6):805-12. PubMed ID: 23562641
[TBL] [Abstract][Full Text] [Related]
14. Interreader and inter-test agreement in assessing treatment response following transarterial embolization for hepatocellular carcinoma.
Donati OF; Do RK; Hötker AM; Katz SS; Zheng J; Moskowitz CS; Beattie C; Brown KT
Eur Radiol; 2015 Sep; 25(9):2779-88. PubMed ID: 25850892
[TBL] [Abstract][Full Text] [Related]
15. Islet cell liver metastases: assessment of volumetric early response with functional MR imaging after transarterial chemoembolization.
Li Z; Bonekamp S; Halappa VG; Corona-Villalobos CP; Pawlik T; Bhagat N; Reyes D; Lai H; Geschwind JF; Kamel IR
Radiology; 2012 Jul; 264(1):97-109. PubMed ID: 22627602
[TBL] [Abstract][Full Text] [Related]
16. Are pancreatic IPMN volumes measured on MRI images more reproducible than diameters? An assessment in a large single-institution cohort.
Pandey P; Pandey A; Varzaneh FN; Ghasabeh MA; Fouladi D; Khoshpouri P; Shao N; Zarghampour M; Hruban RH; Canto M; O'Broin-Lennon AM; Kamel IR
Eur Radiol; 2018 Jul; 28(7):2790-2800. PubMed ID: 29404774
[TBL] [Abstract][Full Text] [Related]
17. Dynamic contrast-enhanced magnetic resonance imaging measurements in renal cell carcinoma: effect of region of interest size and positioning on interobserver and intraobserver variability.
Braunagel M; Radler E; Ingrisch M; Staehler M; Schmid-Tannwald C; Rist C; Nikolaou K; Reiser MF; Notohamiprodjo M
Invest Radiol; 2015 Jan; 50(1):57-66. PubMed ID: 25260094
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Existing Response Criteria in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Using a 3D Quantitative Approach.
Tacher V; Lin M; Duran R; Yarmohammadi H; Lee H; Chapiro J; Chao M; Wang Z; Frangakis C; Sohn JH; Maltenfort MG; Pawlik T; Geschwind JF
Radiology; 2016 Jan; 278(1):275-84. PubMed ID: 26131913
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-Weighted MRI in Patients with Testicular Tumors-Intra- and Interobserver Variability.
Pedersen MRV; Loft MK; Dam C; Rasmussen LÆL; Timm S
Curr Oncol; 2022 Feb; 29(2):837-847. PubMed ID: 35200570
[TBL] [Abstract][Full Text] [Related]
20. Volumetric response classification in metastatic solid tumors on MSCT: initial results in a whole-body setting.
Wulff AM; Fabel M; Freitag-Wolf S; Tepper M; Knabe HM; Schäfer JP; Jansen O; Bolte H
Eur J Radiol; 2013 Oct; 82(10):e567-73. PubMed ID: 23827800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
